Pages that link to "Q36248550"

The following pages link to A systematic review of the effects of nuts on blood lipid profiles in humans (Q36248550):

Displaying 45 items.

• Nut consumption for the primary prevention of cardiovascular disease (Q24186976) (← links)
• Nut consumption for the primary prevention of cardiovascular disease (Q24187668) (← links)
• Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases (Q27002456) (← links)
• Effects of Hazelnut Consumption on Blood Lipids and Body Weight: A Systematic Review and Bayesian Meta-Analysis (Q28076043) (← links)
• Chemical Composition and the Effect of Walnut Hydrosol on Glycemic Control of Patients With Type 1 Diabetes (Q28829618) (← links)
• Nut consumption and risk of type II diabetes in the Physicians' Health Study (Q33575613) (← links)
• Vegetarian Diet in Chronic Kidney Disease-A Friend or Foe. (Q33616816) (← links)
• Long-term intake of nuts in relation to cognitive function in older women (Q33926749) (← links)
• Short-term walnut consumption increases circulating total adiponectin and apolipoprotein A concentrations, but does not affect markers of inflammation or vascular injury in obese humans with the metabolic syndrome: data from a double-blinded, random (Q34072475) (← links)
• The cardio-protective diet (Q34530038) (← links)
• Vegetarian nutrition: Preventive potential and possible risks. Part 1: Plant foods (Q34572915) (← links)
• Effects of adiposity on plasma lipid response to reductions in dietary saturated fatty acids and cholesterol (Q34955169) (← links)
• Health benefits of nut consumption (Q35671008) (← links)
• Effect of almond on technological, nutritional, textural and sensory characteristics of goat meat nuggets (Q36063445) (← links)
• Effect of 12 Weeks High Oleic Peanut Consumption on Cardio-Metabolic Risk Factors and Body Composition (Q36102077) (← links)
• Dietary fibre, nuts and cardiovascular diseases. (Q36662959) (← links)
• Tree nuts and the lipid profile: a review of clinical studies (Q36662968) (← links)
• Assessing the global burden of ischemic heart disease, part 2: analytic methods and estimates of the global epidemiology of ischemic heart disease in 2010 (Q36677176) (← links)
• A single consumption of high amounts of the Brazil nuts improves lipid profile of healthy volunteers. (Q36956109) (← links)
• Walnut consumption is associated with lower risk of type 2 diabetes in women (Q37082306) (← links)
• Effects of hazelnuts consumption on fasting blood sugar and lipoproteins in patients with type 2 diabetes (Q37222144) (← links)
• Functional foods for dyslipidaemia and cardiovascular risk prevention. (Q37651472) (← links)
• Nuts, metabolic syndrome and diabetes (Q37742194) (← links)
• Nuts: Anti-atherogenic food? (Q37852857) (← links)
• Tree nut phytochemicals: composition, antioxidant capacity, bioactivity, impact factors. A systematic review of almonds, Brazils, cashews, hazelnuts, macadamias, pecans, pine nuts, pistachios and walnuts. (Q37966212) (← links)
• Food combinations for cholesterol lowering (Q38052250) (← links)
• SEPP1 polymorphisms modulate serum glucose and lipid response to Brazil nut supplementation. (Q38684220) (← links)
• Polymeric proanthocyanidins from Sicilian pistachio (Pistacia vera L.) nut extract inhibit lipopolysaccharide-induced inflammatory response in RAW 264.7 cells (Q39511359) (← links)
• Nut consumption is inversely associated with both cancer and total mortality in a Mediterranean population: prospective results from the Moli-sani study (Q41446252) (← links)
• Effects of peanut processing on body weight and fasting plasma lipids (Q43067590) (← links)
• The relationship between nut consumption and lipid profile among the Iranian adult population; Isfahan Healthy Heart Program. (Q43747780) (← links)
• Effects of a high walnut and high cashew nut diet on selected markers of the metabolic syndrome: a controlled feeding trial. (Q46447887) (← links)
• Benefits of Nut Consumption on Insulin Resistance and Cardiovascular Risk Factors: Multiple Potential Mechanisms of Actions (Q47161157) (← links)
• Barriers to and facilitators and perceptions of nut consumption among the general population in New Zealand (Q47317403) (← links)
• Fruit and vegetable intake and cognitive decline in middle-aged men and women: the Doetinchem Cohort Study (Q51013448) (← links)
• Dietary Guidelines for Americans 2010: implications for cardiovascular disease. (Q53408763) (← links)
• Nuts: nutrition and health outcomes (Q58419732) (← links)
• Fatty acid composition of nuts – implications for cardiovascular health (Q58419747) (← links)
• Health benefits of nuts: potential role of antioxidants (Q58419751) (← links)
• Current guidelines for nut consumption are achievable and sustainable: a hazelnut intervention (Q59118748) (← links)
• Effect of almond-enriched high-monounsaturated fat diet on selected markers of inflammation: a randomised, controlled, crossover study (Q84815187) (← links)
• Dietary Supplementation with Hazelnut Oil Reduces Serum Hyperlipidemia and Ameliorates the Progression of Nonalcoholic Fatty Liver Disease in Hamsters Fed a High-Cholesterol Diet (Q90193201) (← links)
• Passiflora edulis seed oil from west Cameroon: Chemical characterization and assessment of its hypolipidemic effect in high-fat diet-induced rats (Q91428564) (← links)
• Physicochemical Properties and Health Benefits of Pistachio Nuts (Q91478391) (← links)
• Frailty, Cognitive Decline, Neurodegenerative Diseases and Nutrition Interventions (Q92853287) (← links)